A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome.
A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome.
复制标题
DOI:
10.1016/j.celrep.2015.09.054
复制
发表时间:
2015-11-03
期刊:
影响因子:
8.8
通讯作者:
Des Rosiers C
中科院分区:
文献类型:
--
作者:
Thompson Legault J;Strittmatter L;Tardif J;Sharma R;Tremblay-Vaillancourt V;Aubut C;Boucher G;Clish CB;Cyr D;Daneault C;Waters PJ;LSFC Consortium;Vachon L;Morin C;Laprise C;Rioux JD;Mootha VK;Des Rosiers C
A decline in mitochondrial respiration represents the root cause of a large number of inborn errors of metabolism. It is also associated with common age-associated diseases and the aging process. To gain insight into the systemic, biochemical consequences of respiratory chain dysfunction, we performed a case-control, prospective metabolic profiling study in a genetically homogenous cohort of patients with Leigh syndrome French Canadian variant, a mitochondrial respiratory chain disease due to loss-of-function mutations in LRPPRC. We discovered 45 plasma and urinary analytes discriminating patients from controls, including classic markers of mitochondrial metabolic dysfunction (lactate and acylcarnitines), as well as unexpected markers of cardiometabolic risk (insulin and adiponectin), amino acid catabolism linked to NADH status (α-hydroxybutyrate), and NAD+ biosynthesis (kynurenine and 3-hydroxyanthranilic acid). Our study identifies systemic, metabolic pathway derangements that can lie downstream of primary mitochondrial lesions, with implications for understanding how the organelle contributes to rare and common diseases.